F2 Gene (Prothrombin G20210A) Thrombophilia Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين F2 (البروثرومبين) للكشف عن طفرة التخثر الوريدي بتقنية التسلسل الجيني المتقدم NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing and dual‑bioinformatics verification.
✓ Premium Logistics: Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
✓ Clinical Guidance: Complimentary tele‑post‑test guidance on result interpretation from a clinical consultant.
✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

يقدم هذا التحليل الجيني الشامل تشخيصًا دقيقًا لطفرة جين F2 المسؤولة عن زيادة خطر التخثر الوريدي، مع الالتزام بأعلى معايير الجودة والخصوصية الصحية المعتمدة في دولة الإمارات.

Clinical Overview

The F2 Gene (Prothrombin) G20210A Mutation NGS Test identifies the most common inherited thrombophilia, enabling precise risk stratification for venous thromboembolism. تحليل طفرة جين البروثرومبين الأكثر شيوعًا لتقييم مخاطر التجلط الوريدي الوراثي.

Feature	Our NGS Test	Closest Alternative (PCR)
Methodology	Next‑Generation Sequencing – Full F2 gene analysis	Targeted PCR for G20210A only
Analytical Sensitivity	>99.9% (detects known and novel variants)	~98% (misses rare or compound mutations)
Turnaround Time	3–4 Weeks (comprehensive report)	5–7 Working Days
Clinical Utility	Superior for familial screening & research‑grade resolution	Adequate for direct mutation confirmation

Physician Insights & Safety Protocol

"As a clinician, I always stress that the F2 G20210A mutation is a risk factor, not a destiny – the results must be correlated with personal and family history. Even when positive, many carriers never develop a clot. Your management should be tailored, and never stop prescribed anticoagulants without consulting your doctor."

— Dr. PRABHAKAR REDDY, DHA License No. 61713011

⚠️ Do not discontinue prescribed medication without consulting your treating physician. This test alone does not replace a complete thrombophilia evaluation.

Exclusion Criteria: Active malignancy under treatment, known liver disease with coagulopathy, acute inflammatory states that may transiently affect coagulation.
ER Red Flags: Sudden unilateral leg pain/swelling, pleuritic chest pain, unexplained dyspnoea, or haemoptysis demand immediate emergency evaluation regardless of genetic status.

Patient FAQ & Clinical Guidance

What does the F2 Gene Thrombophilia NGS test detect?

It detects the Prothrombin G20210A mutation, a common genetic risk factor for venous thromboembolism, and analyses the entire coding region of the F2 gene.

يكشف هذا الاختبار عن طفرة البروثرومبين G20210A، وهي عامل خطورة جيني شائع للتجلطات الوريدية، ويحلل جميع مناطق جين F2.

How should I prepare for the and what sample is needed?

No fasting is required; we accept whole blood (EDTA), extracted DNA, or a single drop of blood on an FTA card, collected during home phlebotomy.

لا يحتاج الفحص إلى صيام؛ يمكن استخدام عينة دم كامل، أو حمض نووي مستخلص، أو قطرة دم على بطاقة FTA خلال السحب المنزلي.

When will I receive my results and who will explain them?

Results are available in 3–4 weeks, and a board‑certified consultant will provide a complimentary tele‑guidance session to interpret your genetic risk.

تظهر النتائج خلال 3–4 أسابيع، ويقدم استشاري معتمد جلسة هاتفية مجانية لتفسير المخاطر الوراثية الخاصة بك.

دعم ثنائي اللغة متاح